HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 168 filers reported holding HAEMONETICS CORP in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $1,353 | -99.8% | 16,353 | +137.5% | 0.02% | -40.0% |
Q4 2019 | $791,000 | +89.2% | 6,886 | +108.0% | 0.04% | +150.0% |
Q3 2019 | $418,000 | -82.8% | 3,310 | -88.1% | 0.01% | -86.0% |
Q1 2019 | $2,426,000 | +88.8% | 27,729 | +115.9% | 0.10% | +300.0% |
Q4 2018 | $1,285,000 | +69.1% | 12,843 | +93.5% | 0.02% | +31.6% |
Q3 2018 | $760,000 | -75.6% | 6,637 | -80.9% | 0.02% | -82.4% |
Q2 2018 | $3,112,000 | +161.7% | 34,703 | +113.6% | 0.11% | +176.9% |
Q1 2018 | $1,189,000 | +45.9% | 16,247 | +15.7% | 0.04% | +85.7% |
Q4 2017 | $815,000 | -19.9% | 14,037 | -38.1% | 0.02% | -19.2% |
Q3 2017 | $1,017,000 | -8.5% | 22,659 | -19.4% | 0.03% | -23.5% |
Q2 2017 | $1,111,000 | -2.1% | 28,126 | +0.5% | 0.03% | -2.9% |
Q1 2017 | $1,135,000 | +130.7% | 27,983 | +128.5% | 0.04% | +169.2% |
Q4 2016 | $492,000 | +0.4% | 12,246 | -27.5% | 0.01% | +30.0% |
Q2 2016 | $490,000 | +37.6% | 16,898 | +67.3% | 0.01% | -28.6% |
Q2 2014 | $356,000 | -63.0% | 10,100 | -65.8% | 0.01% | -65.9% |
Q1 2014 | $962,000 | +286.3% | 29,518 | +400.3% | 0.04% | +241.7% |
Q4 2013 | $249,000 | -28.2% | 5,900 | -32.2% | 0.01% | -14.3% |
Q3 2013 | $347,000 | -14.3% | 8,700 | -11.2% | 0.01% | -53.3% |
Q2 2013 | $405,000 | – | 9,800 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Iron Triangle Partners LP | 330,000 | $36,633,000 | 4.66% |
BEACONLIGHT CAPITAL, LLC | 156,395 | $17,361,000 | 2.80% |
Bridge City Capital, LLC | 48,011 | $5,330,000 | 1.77% |
Summit Creek Advisors LLC | 121,362 | $13,472,000 | 1.61% |
Sivik Global Healthcare LLC | 25,000 | $2,775,000 | 1.01% |
ANCHOR CAPITAL ADVISORS LLC | 412,218 | $45,760,000 | 0.97% |
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 69,655 | $7,732,000 | 0.90% |
Orbimed Advisors | 852,000 | $94,581,000 | 0.88% |
LONDON CO OF VIRGINIA | 1,057,738 | $117,420,000 | 0.67% |
WEXFORD CAPITAL LP | 40,138 | $4,456,000 | 0.66% |